Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hemangioma × Saline Solution × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Breast Neoplasms 6 Prostatic Neoplasms 4 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Fallopian Tube Neoplasms 3 Pancreatic Neoplasms 2 Pain, Postoperative 2 Lymphoma 2 Hemorrhage 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thromboembolism 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Peritoneal Neoplasms 1 Peripheral Nervous System Diseases 1 Pancreatic Cyst 1 Pain 1 Non-Muscle Invasive Bladder Neoplasms 1 Neurotoxicity Syndromes 1 Myofibroma 1 Multiple Myeloma 1 Metabolic Diseases 1 Melanoma 1 Lymphoma, Non-Hodgkin 1

Interventions

Propranolol 3 Sodium Chloride 1 Saline Solution 1 Prednisolone 1 Nadolol 1 Methylprednisolone 1 Atenolol 1 Acebutolol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01685398 2023-09-21

Topical Timolol for Superficial Infantile Hemangioma

Mahidol University

Phase 3 Completed

Hemangioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡